Back to company

Vesper Bio ApS: Financial statements 2013

CVR: 32879861

Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -2,554,127 compared with DKK -16,199 the year before. Equity amounted to DKK 12,574,628. The solvency ratio was 97.2%.

Profit/Loss
-2,554,127 kr.
Equity
12,574,628 kr.
Total Assets
12,939,088 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013---2.6 mio.12.6 mio.-
2012--22 t.-16 t.377 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Vesper Bio ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

Vesper Bio ApS appoints new auditorAug 1, 2013

As of August 1, 2013, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Vesper Bio ApS.

Auditor steps down at Vesper Bio ApSAug 1, 2013

As of August 1, 2013, JUT NR. 2124 ApS has stepped down as auditor of Vesper Bio ApS.

Vesper Bio ApS appoints new auditorJul 1, 2013

As of July 1, 2013, JUT NR. 2124 ApS has been appointed auditor of Vesper Bio ApS.

Auditor steps down at Vesper Bio ApSJul 1, 2013

As of July 1, 2013, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Vesper Bio ApS.

Vesper Bio ApS: The 2012 annual report is outJun 10, 2013

Vesper Bio ApS has published its annual report for 2012. Gross profit came to DKK -21,599, and the net result was DKK -16,199.

Christian Ellebæk Elling joins Vesper Bio ApS as adm. dir.May 30, 2013

As of May 30, 2013, Christian Ellebæk Elling is registered as adm. dir. of Vesper Bio ApS.

Anders Nykjær steps down as adm. dir. of Vesper Bio ApSMay 30, 2013

As of May 30, 2013, Anders Nykjær has stepped down as adm. dir. of Vesper Bio ApS.

About Vesper Bio ApS

Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.